Galia Rahav to Aged, 80 and over
This is a "connection" page, showing publications Galia Rahav has written about Aged, 80 and over.
Connection Strength
0.090
-
Humoral Response of Renal Transplant Recipients to the BNT162b2 SARS-CoV-2 mRNA Vaccine Using Both RBD IgG and Neutralizing Antibodies. Transplantation. 2021 11 01; 105(11):e234-e243.
Score: 0.027
-
Isavuconazole for treatment of rare invasive fungal diseases. Mycoses. 2018 Aug; 61(8):518-533.
Score: 0.022
-
Prevalence of Allergic Reactions After Pfizer-BioNTech COVID-19 Vaccination Among Adults With High Allergy Risk. JAMA Netw Open. 2021 08 02; 4(8):e2122255.
Score: 0.007
-
Myocardial injury in hospitalized patients with COVID-19 infection-Risk factors and outcomes. PLoS One. 2021; 16(2):e0247800.
Score: 0.006
-
Utilization of machine-learning models to accurately predict the risk for critical COVID-19. Intern Emerg Med. 2020 Nov; 15(8):1435-1443.
Score: 0.006
-
Differences in the expression of SPI-1 genes pathogenicity and epidemiology between the emerging Salmonella enterica serovar Infantis and the model Salmonella enterica serovar Typhimurium. J Infect Dis. 2019 08 09; 220(6):1071-1081.
Score: 0.006
-
Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection in Patients at Increased Risk for Recurrence. Clin Infect Dis. 2018 08 16; 67(5):649-656.
Score: 0.005
-
The herd effects of infant PCV7/PCV13 sequential implementation on adult invasive pneumococcal disease, six years post implementation; a nationwide study in Israel. Vaccine. 2017 04 25; 35(18):2449-2456.
Score: 0.005
-
Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection. N Engl J Med. 2017 01 26; 376(4):305-317.
Score: 0.005